Thrombosis Flashcards

1
Q

describe consequences of thrombosis and thromboembolism

A
  1. obstructive shock: due to
    -impaired regional oxygen delivery
    -impaired blood flow
  2. organ dysfunction/failure
    -primarily microthrombosis
  3. complicates therapy:
    -catheter associated thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe diagnosis of thrombosis

A
  1. physical exam
    -one extremity colder than the others
    -ischemic muscles are painful and hard (ischemic myopathy)
    -thrombophlebitis characterized by warmth and swelling over vein, usually at site of prior venipuncture or catheter
    -acutely painful abdomen: thrombosis of GI tract
  2. signs of organ failure:
    -pulmonary thromboembolism characterized by acute onset dyspnea
    -acute kidney injury
    -hepatic injury
    -stroke or other acute neuro dysfunction
  3. sudden death may occur from massive thrombosis
  4. ultrasound or other imaging (CT) may ID thrombi in situ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe virchow’s triad of hypercoagulability

A
  1. endothelial damage/dysfunction
    -alterations of glycocalyx exposing procoagulant triggers: due to inflammation, fluid therapy, or direct injury

-release of vWF: from activated endothelial cells

  1. hypercoagulable state: either

-increased procoagulant proteins: due to sepsis, inflammation, post-surgery (fibrinogen increase), hyperadrenocorticism, heritability

OR

-decreased anticoagulant proteins: sepsis, inflammation, loss (GI, renal)

  1. blood stasis/alterations in blood flow

-activation of intrinsic pathway: decreased or abnormal blood flow

-intravascular foreign material: negative charge or biofilm production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe arterial versus venous thrombosis

A
  1. arterial clots are white clots
    -predominantly composed of platelets = white
    -activated/tickled with high shear blood flow
    -antiplatelet agents as primary therapy
  2. venous clots are red clots:
    -low pressure/venous stasis
    -rich in fibrin and erythrocytes = red
    -anticoagulant agents as primary therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

related cardiac disease to thrombosis

A
  1. feline cardiac disease:
    -left atrial dilation, spontaneous echocontrast, reduced left atrial appendage velocity are all risk factors

-thromboembolic sequelae primarily: arterial thromboembolism (ATE)

  1. heartworm/ pulmonary artery thrombosis
    -worm thrombus versus clot; both are bad
  2. transvenous pacemakers: uncommon but can cause clot formation on lead
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

relate immune mediated hemolytic anemia to thromboemboli

A
  1. strongly associated with thrombosis in dogs!!!
  2. anticoagulation is standard component of therapy
  3. risk factors include:
    -severe inflammatory response: high fibrinogen, decreased antithrombin, RBC membranes in circulation (good spot for clotting factors to set up)

-CSA therapy

-IV access

-multiple blood transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe protein losing conditions and thromboemboli

A
  1. protein losing nephropathy:
    -associated with thrombosis
    -presumably due to loss of antithrombin
  2. protein losing enteropathy
    -loss of proteins including antithrombin
    -small and large animals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

relate glucocorticoids and hyperadrenocortism to thrombosis

A
  1. treatment with corticosteroids is associated with hypercoagulable state
  2. hyepradrenocorticism (dogs)
    -may favor hypercoagulable state
    -considered to be a risk factor
    -elevated: factors II, V, VII, IX, X, XII, fibrinogen, thrombin-antithrombin complexes, antithrombin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

relate infectious disease to thrombosis

A

primarily due to causing inflammation!

  1. dogs with depsis without coagulopathy are at risk of thrombosis
  2. small subset of cats with sepsis
  3. neonatal sepsis: foals, presence of coagulopathy worsens prognosis
  4. EHV-1 infection in adult horses: vasculitis, thrombosis leads to myeloencephalopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

relate equie gastrointestinal disease to thrombosis

A
  1. jugular thrombophlebitis or other thrombosis
    -ischemic/strangulating GI lesions
    -colitis
    -duadenitis/proximal jejunitis
    -right dorsal colitis
  2. jugular thrombophlebitis more likely in horses with surgically treated colic that develop fever or diarrhea
  3. salmonellosis is also a risk factor
  4. thrombosis may initiate at venipuncture site or on catheter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

relate neoplasia, cerebrovascular disease, pancreatitis, and extracorporeal circuits to thrombosis

A

neoplasia:
-carcinomas in dogs associated with risk

cerebrovascular disease: may result from thrombotic event rather than cause one

pancreatitis: dogs

extracorporeal circuits (dialysis): activates coag during treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

relate vascular access/devices to thrombosis

A

transvenous pacemaker leads

IV catheters:
-central lines
-catheter-associated thrombi generally in patients with severe inflammation
-catheter alone not usually a risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when are anticoagulant drugs indicated?

A
  1. in animals with existing thrombi/thromboembolism
  2. in animals with a single strong risk factor
  3. animals with multiple moderate risk factors
  4. ALWAYS indicated for dogs with IMHA and cats with heart disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe anticoagulant drugs

A
  1. no clear evidence of one superior drug
  2. include antiplatelet, antithrombotic, and fibrinolytic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe clopidogrel (plavix)

A
  1. P2Y12 ADP receptor inhibitor:
    -decreases degree of platelet aggregation
    -decreases platelet activation state
  2. prodrug:
    -requires hepatic conversion
    -P450-dependent so individual variability
  3. irreversible block of receptor!
    -will stay blocked for platelet life (approx 5 days, so need 7 days after stopping drug to return to full platelet function, more like 3 days clinically bc bone marrow always making platelets)
  4. effective in dogs, cats, and horses
    -dogs: rapid onset
    -horses: variable onset and termination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

acetylsalicylic acid (ASA; aspirin)

A
  1. inhibits cyclooxygenase (COX)
    -prevents production of arachidonic acid metabolite thromboxane A2
  2. thromboxane A2 is potent platelet agonist, vasoconstrictor
  3. irreversible inhibition of COX
    -low dose can get by and will work eventually while avoiding spicier side effects for humans, but does not work as well in pets
  4. decreases platelet aggregation in dogs
    -reliably impacts platelet aggregation in cats or horses
  5. NSAID tox: GI ulceration and bleeding, renal impairment depending on dose
    -also these patients are often also treated with corticosteroids = BAD NEWS BEARS TO MIX

rarely used clinically anymore, esp since clopridogrel so available now!

17
Q

describe heparin (anticoagulant drug)

A
  1. potentiates antithrombin inhibition
  2. unfractionated:
    -binds antithrombin and factors IIa and Xa
    -stabilizes thrombin-antithrombin complex
    -in dogs, cats, horses at risk of thrombosis, give IV or SQ
    -individual variation in optimal dose likely
    -can cause erythrocyte agglutination and thrombocytopenia in horses
  3. low-molecular weight heparin:
    -binds Xa but cannot stabilize interaction of thrombin
    -associated with lower risk of uncontrolled hemorrhage!
    -used in dogs, cats, and horses with variable dosing intervals
    -more predictable PK/PD, NOT associated with RBC agglutination in horses
  4. can measure anti-Xa activity to dose either; directly related to drug concentration
18
Q

describe heparin for hyperlipemia in horses

A

hyperlipemia increases release of lipoprotein release and increases release of hepatic lipase

LMWH may prevent platelet activation from EHV-1 and prevent adhesions

19
Q

describe direct Xa inhibitors

A
  1. rivaroxaban (xarelto), apixaban (elliquis)
  2. inhibit factor Xa directly
    -no need for antithrombin
    -inhibits free Xa AND Xa in prothrombase complex
  3. predictable PK; not impacted by food
  4. irreversible inhibition of Xa
    -problematic for rapid reversal of drug effect
  5. well-tolerated in dogs and cats
20
Q

describe antiplatelet agents vs anticoagulatants for ATE

A

dogs:
1. antiplatelet agents may be more effective vs anticoagulants for prevention of ATE
2. anticoagulants may also be effective for prevention of ATE

cats:
1. recommend clopridogrel for prevention of ATE
2. no recs regarding anticoagulants
3. combo therapy?
-in people is associated with higher risk of bleeding, we really dont know tbh

21
Q

describe fibrinolytic drugs

A
  1. tissue plasminogen activator (tPA):
    -injectable activator of plasmin
    -rapid effect: may cause reperfusion injury
    -breaks down all clots
  2. catheter delivered may be superior
  3. must use early
    -best for cats with an ACUTE thromboembolism; beyond that risk of severe uncontrollable hemorrhage that is too old for tPA to break down is not worth it